Clinical Trials Logo

Filter by:
NCT ID: NCT05072327 Recruiting - Eyelid Tumor Clinical Trials

Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

This study aim to investigate whether the prognosis of eyelid malignant tumor is better treated with Mohs surgery combind with cryotherapy than Mohs surgery only.

NCT ID: NCT05071742 Recruiting - Clinical trials for Inflammatory Bowel Disease

Correlation of Genetic Susceptibility Genes to Inflammatory Bowel Disease in Chinese Han Population

CGSGIBDCHP
Start date: November 25, 2021
Phase:
Study type: Observational

The pathogenesis of IBD is still unclear, and the disease characteristics of IBD patients are affected by genetic susceptibility genes. Therefore, this study aims to explore the relationship between genetic susceptibility genes of IBD and the pathogenesis of IBD in Chinese Han population, in order to clarify the pathogenesis of IBD and provide basis for individualized treatment of IBD.

NCT ID: NCT05071482 Recruiting - Acute Leukemia Clinical Trials

Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL

Start date: September 16, 2021
Phase: Phase 4
Study type: Interventional

Compared with patients with philadelphia chromosome-negative Acute Lymphoblastic Leukemia (Ph- ALL), patients with Ph-positive (Ph+) ALL exhibit a comparatively poor prognosis. Fortunately, significant improvements have been found in response rates, disease-free survival (DFS), and overall survival (OS) for patients with Ph+ ALL with the introduction of tyrosine kinase inhibitor (TKI) therapy to treatment regimens. Based on improvements in efficacy and tolerability, next-generation TKIs have been widely used in first-line treatment for chronic myeloid leukemia (CML). Flumatinib, a TKI with more potent binding affinity for BCR-ABL1 tyrosine kinase than imatinib, demonstrated higher rates of responses, faster and deeper responses in FESTnd trial, which suggested that flumatinib might show improved clinical efficacy for treating Ph+ ALL compared with imatinib. The investigators therefore hypothesized that the addition of flumatinib to combinatorial chemotherapy regimen would demonstrate greater efficacy compared with the prior use of imatinib in treating Ph+ ALL. This study explored the safety and efficacy of flumatinib versus imatinib when combined with multi-agent chemotherapy in patients with newly diagnosed Ph+ ALL.

NCT ID: NCT05070611 Recruiting - Chalazion Clinical Trials

Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The purpose of the present study was to investigate the efficacy of intense pulse light and meibomian glands expression in cases of recurrent chalazion after surgery.

NCT ID: NCT05070598 Recruiting - Clinical trials for HER2-positive Gastric Cancer

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

Start date: September 7, 2021
Phase: Phase 2
Study type: Interventional

According to the investigator's judgment, there are concomitant diseases that seriously endanger the patient's safety, or affect the patient's completion of the study (such as uncontrolled hypertension, diabetes, thyroid disease, etc.);

NCT ID: NCT05069857 Recruiting - Clinical trials for Oral Squamous Cell Carcinoma

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of neoadjuvant anti-PD-1 plus anti-VEGFR therapy for patients with locally advanced and resectable oral squamous cell carcinoma, and the CPS>10 in the biopsy samples.

NCT ID: NCT05069571 Recruiting - Clinical trials for Colorectal Neoplasms

Endoangel Withdrawal Overspeed Analysis

Start date: March 1, 2020
Phase:
Study type: Observational

Exploring the relationship between the percentage of overspeed of colonoscopy withdrawal and the rate of adenoma detection.

NCT ID: NCT05069467 Recruiting - Prostate Cancer Clinical Trials

Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)

AVAIL
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Hot flashes are a common and debilitating symptom among prostate cancer patients undergoing androgen deprivation therapy (ADT). Strong evidence from multiple rigorously designed studies indicated that venlafaxine provides partial relief, but the tolerability is poor when the dose is not tapered. Hence, an alternative therapy is needed. Previous studies reported that acupuncture may be helpful in the management of hot flashes. However, the insufficient randomized controlled trial limited the quality of evidence.

NCT ID: NCT05069441 Recruiting - Clinical trials for Mechanical Ventilation

Prediction of Extubation Failure: A Multicenter Prospective Observational Study

Start date: October 15, 2021
Phase:
Study type: Observational

The investigators intend to collect several variables to predict extubation failure among patients who successfully complete a spontaneous breathing trial, and then develop a scale using simple bedside indicators to predict extubation failure.

NCT ID: NCT05069233 Recruiting - Stomach Diseases Clinical Trials

Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small Intestine

Start date: September 27, 2021
Phase:
Study type: Observational

In this study, we retrospectively analyzed the videos of combined upper digestive tract and small intestine examination under MCE, so as to clarify the feasibility and diagnostic efficacy of MCE in one-time examination of the upper gastrointestinal and small intestinal mucosa.